| . | PGS (−) . | PGS (+) . | . |
|---|---|---|---|
| . | P = 70 . | P = 12 . | . |
| Graft type | >0.99 a | ||
| Triplex, n (%) | 54 (77.1) | 9 (75.0) | |
| J-graft, n (%) | 16 (22.9) | 3 (25.0) | |
| Graft configuration | 0.054 a | ||
| TAR + FET, n (%) | 45 (64.3) | 4 (33.3) | |
| AAR, n (%) | 21 (30.0) | 8 (66.7) | |
| Others, n (%) | 4 (5.7) | 0 (0.0) | |
| Operation time (min) | 270.0 [244.0, 360.0] | 260.0 [248.3, 350.0] | 0.773 c |
| OSG length (mm) | 60.0 [60.0, 90.0] | 60.0 [60.0, 82.5] | 0.446 c |
| Haemostatic agent (%) | 28 (40.0) | 9 (75.0) | 0.031 a |
| Concomitant op, n (%) | 16 (22.8) | 2 (16.7) | 0.722 a |
| Arrest time (min) | 167.0 [148.0, 206.0] | 162.0 [150.8, 192.3] | 0.973 c |
| CPB time (min) | 201.0 [173.3, 247.3] | 191.5 [175.3, 203.5] | 0.609 c |
| Intubation length (days) | 2.7 [1.7, 5.3] | 2.4 [1.7, 3.7] | 0.61 c |
| ICU stay (day) | 7.0 [5.0, 13.3] | 6.0 [4.0, 9.8] | 0.42 c |
| Complications, n (%) | 34 (48.6) | 4 (33.3) | 0.367 a |
| Stroke | 13 (18.1) | 0 (0) | 0.351 a |
| Pneumonia | 4 (5.6) | 0 (0) | >0.999 a |
| Renal failure | 2 (2.8) | 0 (0) | >0.999 a |
| Urinary tract infection | 5 (6.9) | 1 (10) | 0.554 a |
| Thirty-day mortality | |||
| Death, n (%) | 3 (4.3) | 0 (0.0) | >0.99 a |
| Five-year mortality | |||
| Death, n (%) | 10 (21.3) | 2 (50.0) | 0.232 a |
| . | PGS (−) . | PGS (+) . | . |
|---|---|---|---|
| . | P = 70 . | P = 12 . | . |
| Graft type | >0.99 a | ||
| Triplex, n (%) | 54 (77.1) | 9 (75.0) | |
| J-graft, n (%) | 16 (22.9) | 3 (25.0) | |
| Graft configuration | 0.054 a | ||
| TAR + FET, n (%) | 45 (64.3) | 4 (33.3) | |
| AAR, n (%) | 21 (30.0) | 8 (66.7) | |
| Others, n (%) | 4 (5.7) | 0 (0.0) | |
| Operation time (min) | 270.0 [244.0, 360.0] | 260.0 [248.3, 350.0] | 0.773 c |
| OSG length (mm) | 60.0 [60.0, 90.0] | 60.0 [60.0, 82.5] | 0.446 c |
| Haemostatic agent (%) | 28 (40.0) | 9 (75.0) | 0.031 a |
| Concomitant op, n (%) | 16 (22.8) | 2 (16.7) | 0.722 a |
| Arrest time (min) | 167.0 [148.0, 206.0] | 162.0 [150.8, 192.3] | 0.973 c |
| CPB time (min) | 201.0 [173.3, 247.3] | 191.5 [175.3, 203.5] | 0.609 c |
| Intubation length (days) | 2.7 [1.7, 5.3] | 2.4 [1.7, 3.7] | 0.61 c |
| ICU stay (day) | 7.0 [5.0, 13.3] | 6.0 [4.0, 9.8] | 0.42 c |
| Complications, n (%) | 34 (48.6) | 4 (33.3) | 0.367 a |
| Stroke | 13 (18.1) | 0 (0) | 0.351 a |
| Pneumonia | 4 (5.6) | 0 (0) | >0.999 a |
| Renal failure | 2 (2.8) | 0 (0) | >0.999 a |
| Urinary tract infection | 5 (6.9) | 1 (10) | 0.554 a |
| Thirty-day mortality | |||
| Death, n (%) | 3 (4.3) | 0 (0.0) | >0.99 a |
| Five-year mortality | |||
| Death, n (%) | 10 (21.3) | 2 (50.0) | 0.232 a |
P-value: (a) unpaired t-test; (b) Fisher's exact test; and (c) Mann–Whitney U test. Values are presented as number (%) or mean (SD) or median [IQR].
AAR: ascending aortic replacement; CPB: cardiopulmonary bypass; ICU: intensive care unit; IQR: interquartile range; op: operation; OSG: open stent graft; PGS: perigraft seroma; SD: standard deviation; TAR + FET: total arch replacement + frozen elephant trunk.
| . | PGS (−) . | PGS (+) . | . |
|---|---|---|---|
| . | P = 70 . | P = 12 . | . |
| Graft type | >0.99 a | ||
| Triplex, n (%) | 54 (77.1) | 9 (75.0) | |
| J-graft, n (%) | 16 (22.9) | 3 (25.0) | |
| Graft configuration | 0.054 a | ||
| TAR + FET, n (%) | 45 (64.3) | 4 (33.3) | |
| AAR, n (%) | 21 (30.0) | 8 (66.7) | |
| Others, n (%) | 4 (5.7) | 0 (0.0) | |
| Operation time (min) | 270.0 [244.0, 360.0] | 260.0 [248.3, 350.0] | 0.773 c |
| OSG length (mm) | 60.0 [60.0, 90.0] | 60.0 [60.0, 82.5] | 0.446 c |
| Haemostatic agent (%) | 28 (40.0) | 9 (75.0) | 0.031 a |
| Concomitant op, n (%) | 16 (22.8) | 2 (16.7) | 0.722 a |
| Arrest time (min) | 167.0 [148.0, 206.0] | 162.0 [150.8, 192.3] | 0.973 c |
| CPB time (min) | 201.0 [173.3, 247.3] | 191.5 [175.3, 203.5] | 0.609 c |
| Intubation length (days) | 2.7 [1.7, 5.3] | 2.4 [1.7, 3.7] | 0.61 c |
| ICU stay (day) | 7.0 [5.0, 13.3] | 6.0 [4.0, 9.8] | 0.42 c |
| Complications, n (%) | 34 (48.6) | 4 (33.3) | 0.367 a |
| Stroke | 13 (18.1) | 0 (0) | 0.351 a |
| Pneumonia | 4 (5.6) | 0 (0) | >0.999 a |
| Renal failure | 2 (2.8) | 0 (0) | >0.999 a |
| Urinary tract infection | 5 (6.9) | 1 (10) | 0.554 a |
| Thirty-day mortality | |||
| Death, n (%) | 3 (4.3) | 0 (0.0) | >0.99 a |
| Five-year mortality | |||
| Death, n (%) | 10 (21.3) | 2 (50.0) | 0.232 a |
| . | PGS (−) . | PGS (+) . | . |
|---|---|---|---|
| . | P = 70 . | P = 12 . | . |
| Graft type | >0.99 a | ||
| Triplex, n (%) | 54 (77.1) | 9 (75.0) | |
| J-graft, n (%) | 16 (22.9) | 3 (25.0) | |
| Graft configuration | 0.054 a | ||
| TAR + FET, n (%) | 45 (64.3) | 4 (33.3) | |
| AAR, n (%) | 21 (30.0) | 8 (66.7) | |
| Others, n (%) | 4 (5.7) | 0 (0.0) | |
| Operation time (min) | 270.0 [244.0, 360.0] | 260.0 [248.3, 350.0] | 0.773 c |
| OSG length (mm) | 60.0 [60.0, 90.0] | 60.0 [60.0, 82.5] | 0.446 c |
| Haemostatic agent (%) | 28 (40.0) | 9 (75.0) | 0.031 a |
| Concomitant op, n (%) | 16 (22.8) | 2 (16.7) | 0.722 a |
| Arrest time (min) | 167.0 [148.0, 206.0] | 162.0 [150.8, 192.3] | 0.973 c |
| CPB time (min) | 201.0 [173.3, 247.3] | 191.5 [175.3, 203.5] | 0.609 c |
| Intubation length (days) | 2.7 [1.7, 5.3] | 2.4 [1.7, 3.7] | 0.61 c |
| ICU stay (day) | 7.0 [5.0, 13.3] | 6.0 [4.0, 9.8] | 0.42 c |
| Complications, n (%) | 34 (48.6) | 4 (33.3) | 0.367 a |
| Stroke | 13 (18.1) | 0 (0) | 0.351 a |
| Pneumonia | 4 (5.6) | 0 (0) | >0.999 a |
| Renal failure | 2 (2.8) | 0 (0) | >0.999 a |
| Urinary tract infection | 5 (6.9) | 1 (10) | 0.554 a |
| Thirty-day mortality | |||
| Death, n (%) | 3 (4.3) | 0 (0.0) | >0.99 a |
| Five-year mortality | |||
| Death, n (%) | 10 (21.3) | 2 (50.0) | 0.232 a |
P-value: (a) unpaired t-test; (b) Fisher's exact test; and (c) Mann–Whitney U test. Values are presented as number (%) or mean (SD) or median [IQR].
AAR: ascending aortic replacement; CPB: cardiopulmonary bypass; ICU: intensive care unit; IQR: interquartile range; op: operation; OSG: open stent graft; PGS: perigraft seroma; SD: standard deviation; TAR + FET: total arch replacement + frozen elephant trunk.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
